RhoH
RhoH is a small GTPase belonging to the Rho family of proteins, which play a critical role in regulating various cellular processes such as cell morphology, cell migration, cell cycle progression, and gene expression. Unlike most members of the Rho family, RhoH is unique in that it is predominantly expressed in hematopoietic cells, including both myeloid and lymphoid lineages, and is involved in controlling the immune system's function.
Function[edit | edit source]
RhoH acts as a regulatory molecule within cells, modulating the actin cytoskeleton to influence cell shape and movement. It is also involved in T-cell receptor (TCR) signaling, playing a crucial role in T-cell development and activation. RhoH's unique feature is its inability to hydrolyze GTP, which means it remains constitutively active once expressed. This characteristic allows it to act as a modulator of signaling pathways rather than a direct signal transducer.
Gene and Expression[edit | edit source]
The gene encoding RhoH is located on chromosome 4 in humans. Its expression is tightly regulated, with high levels observed in hematopoietic tissues. Aberrant expression of RhoH has been implicated in various hematological malignancies, including leukemia and lymphoma, suggesting its role in the development and progression of these cancers.
Clinical Significance[edit | edit source]
Alterations in RhoH expression or function have been associated with several diseases, particularly those affecting the hematopoietic system. Overexpression or underexpression of RhoH can disrupt normal cellular processes, leading to the development of malignancies. Furthermore, mutations in the RhoH gene have been identified in certain types of cancer, highlighting its potential as a target for therapeutic intervention.
Research[edit | edit source]
Ongoing research is focused on elucidating the precise mechanisms by which RhoH functions within cells and its interactions with other proteins. Understanding the role of RhoH in disease pathogenesis, particularly in hematological malignancies, could lead to the development of novel therapeutic strategies targeting this protein.
See Also[edit | edit source]
References[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD